Health
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Key Points
Daraxonrasib, the first drug of its type, has electrified pancreatic cancer specialists and patients because it has shown it can double life expectancy.
Daraxonrasib, the first drug of its type, has electrified pancreatic cancer specialists and patients because it has shown it can double life expectancy.